There are 2789 resources available
1071P - A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients
Presenter: Eva Ellebaek
Session: ePoster Display
1072P - Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome
Presenter: Emilia Cocorocchio
Session: ePoster Display
1073P - Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial
Presenter: Sapna Patel
Session: ePoster Display
1125P - Analytical assessment of a diagnostic immunohistochemical assay for the detection of folate receptor-ɑ in epithelial ovarian cancers
Presenter: Racheal James
Session: ePoster Display
1053P - Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma
Presenter: Timothy Humphries
Session: ePoster Display
1054P - FDG-PET to predict long-term outcome from anti-PD1 (PD1) therapy in metastatic melanoma
Presenter: Florentia Dimitriou
Session: ePoster Display
1128P - Genotypic and phenotypic evaluation of the pharmacokinetics of irinotecan and its relationship with the occurrence of toxicity in the treatment of cancer
Presenter: Jeziel Basso
Session: ePoster Display
1129P - Comparison of predictive value of ASIA criteria and PD-L1 expression in patients taking checkpoint inhibitors in real clinical practice
Presenter: Natalia Zhukova
Session: ePoster Display
1130P - Anchored multiplex PCR-based targeted sequencing for the detection of fusion transcripts in FFPE samples of non-small cell lung cancer patients
Presenter: Audrey Vallée
Session: ePoster Display
1131P - Intraoperative assessment of negative resection margins in breast-conserving surgery using optical coherence elastography
Presenter: Ekaterina Gubarkova
Session: ePoster Display